BioSpace News Archive

Policy

Bright Settles Dismissal Complaint While Whistleblower Case Continues

The Trump White House removed Bright from his position at BARDA and reassigned him to a narrower role at the National Institutes of Health.

August 10, 2021
·
2 min read
·
Alex Keown
Business

Santen, Sydnexis Unite to Vanquish Childhood Myopia

Global biopharmaceutical firms Santen SA and Sydnexis have entered an exclusive licensing deal for a drug formulation that aims to treat progressive myopia.

August 10, 2021
·
2 min read
·
Vanessa Doctor, RN
Pharm Country

Fera Pharma Pounces on Abandoned Pfizer Pediatric Glaucoma Drug

Pfizer has made a deal with the small Locust Valley, New York-based company to manufacture and market the drug.

August 10, 2021
·
2 min read
·
Mark Terry
Business

Gilead Joins Growing List of Biopharma Companies Mandating COVID-19 Vaccination

As the Delta variant rages on and COVID-19 vaccines move closer to receiving full regulatory approval, many companies across the U.S. and abroad are beginning to mandate their employees get the jab or get the boot.

August 10, 2021
·
2 min read
·
Brandon May
Business

Money on the Move: August 4 – 10

Check out where the money went in the life sciences industry this week.

August 10, 2021
·
3 min read
·
Kate Goodwin
Embolization Particles Market: Rise in Prevalence of Lymphoma & Myeloma Cancers to Drive the Market

Embolization is a minimally invasive procedure that blocks blood flow to a particular area of the body, leading to effective shrinkage of an aneurysm or a tumor.

August 10, 2021
·
4 min read
Bacterial Vaccines Market: Rising awareness for preventive medicine to prevent bacterial diseases to drive the market

Worldwide, the rising awareness for preventive medicine to prevent bacterial diseases is the foremost factor driving the bacterial vaccines market.

August 10, 2021
·
4 min read
Business

IDEAYA Biosciences, Inc. Reports Second Quarter 2021 Financial Results and Provides Business Update

IDEAYA Biosciences, Inc., a synthetic lethality focused precision medicine oncology company committed to the discovery and development of targeted therapeutics, provided a business update and announced financial results for the second quarter ended June 30, 2021.

August 10, 2021
·
19 min read
Biotech Beach

Kurin, Inc. Reports Record Sales Month

Kurin Inc., the inventor and manufacturer of the Kurin® blood culture collection sets, announced that July revenues represent their highest monthly total in their history.

August 10, 2021
·
1 min read
Business

Itamar Medical Reports Second Quarter 2021 Financial Results

Itamar Medical Ltd., a leading medical device and digital health company focused on the integration of sleep apnea management into the cardiac patient care pathway, reported unaudited financial results for the second quarter of 2021.

August 10, 2021
·
20 min read